Trials / Completed
CompletedNCT00965978
A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation
A Study to Evaluate Food Effect on Pharmacokinetics Parameters After Administration of ONO-5920/YM529 Intermittent Formulation
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- Female
- Age
- 45 Years – 81 Years
- Healthy volunteers
- Accepted
Summary
The aim of the study is to evaluate the effects of food intake on the plasma concentration profile of YNO-5920/YM529 in post menopausal women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-5920 / YM529 | oral |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2009-09-01
- Completion
- 2009-09-01
- First posted
- 2009-08-26
- Last updated
- 2009-10-05
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00965978. Inclusion in this directory is not an endorsement.